Physician profile
Zakia Rahman
NPI 1538272752
$180,930.60
in general payments reported to CMS, 2019-2025
6 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $12K · 2021: $4,294 · 2022: $24K · 2023: $49K · 2024: $55K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $16K · Food and Beverage: $3,682 · Gift: $43.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,291.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,913.72 |
| Travel and Lodging | $15,552.32 |
| Food and Beverage | $3,681.50 |
| Gift | $43.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $127,147.15 | 2022-2025 | |
| Allergan, INC. | $33,994.16 | 2019-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $14,043.70 | 2019-2020 | |
| Lumenis, INC | $5,200.00 | 2019 | |
| Merz North America, INC. | $292.00 | 2019-2024 | |
| Galderma Laboratories, L.P. | $253.59 | 2019-2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zakia Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.